Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001261734-09-000039
Filing Date
2009-12-28
Accepted
2009-12-28 10:58:40
Documents
16
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K - FISCAL YEAR ENDED SEPTEMBER 30, 2009 form10k.htm 10-K 1761445
2 LIST OF SUBSIDIARIES ex211-subs.htm EX-21.1 1324
3 CONSENT OF HASKELL & WHITE LLP ex231-hwconsent.htm EX-23.1 4383
4 CEO CERTIFICATION ex311.htm EX-31.1 14637
5 CFO CERTIFICATION ex312.htm EX-31.2 14672
6 CEO-CFO CERTIFICATION PURSUANT TO 18 U.S.C. 1350 AS ADOPTED PURSUANT TO SECTION ex321.htm EX-32.1 8092
7 FIGURE 1 figure1.jpg GRAPHIC 38237
8 FIGURE 2 figure2.jpg GRAPHIC 43022
9 FIGURE 3 figure3.jpg GRAPHIC 36549
10 FIGURE 4 figure4.jpg GRAPHIC 100740
11 FIGURE 5 figure5.jpg GRAPHIC 69228
12 FIGURE 6 figure6.jpg GRAPHIC 72557
13 FIGURE 7 figure7.jpg GRAPHIC 94195
14 FIGURE 8 figure8.jpg GRAPHIC 116163
15 FIGURE 9 figure9.jpg GRAPHIC 109656
16 FIGURE 10 figure10.jpg GRAPHIC 53119
  Complete submission text file 0001261734-09-000039.txt   2818123
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-50481 | Film No.: 091260961
SIC: 2834 Pharmaceutical Preparations